Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
about
Metabonomic window into hepatitis B virus-related hepatic diseasesLiver transplantation for viral hepatitis in 2015Era of direct acting antivirals in chronic hepatitis C: Who will benefit?Μanagement of patients with hepatitis B and C before and after liver and kidney transplantationManagement of patients with hepatitis B in special populationsRole of antiviral therapy in the natural history of hepatitis B virus-related chronic liver diseaseEpidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosisComparison of collagen proportionate areas in liver fibrosis quantification between chronic hepatitis B and CA serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis.Virus-related liver cirrhosis: molecular basis and therapeutic options.Hepatitis B viral load affects prognosis of hepatocellular carcinoma.Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China.Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study.Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.Altered Immune Profiles of Natural Killer Cells in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis.Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapyEstimated Glomerular Filtration Rate Increases in Chronic Hepatitis B Patients Treated With Telbivudine Monotherapy and Combination Treatment.Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.New universal primers for genotyping and resistance detection of low HBV DNA levels.Impact of therapy on the outcome of chronic hepatitis B.Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosis.Intrahepatic cholestasis in common chronic liver diseases.Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.Improving clinical outcomes of chronic hepatitis B virus infection.Monotherapy for hepatitis B infection: a review of treatment options.Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.Stepwise Application of FIB-4, Red cell distribution width-Platelet Ratio and APRI for Compensated Hepatitis B Fibrosis Detection.Direct antiviral agent treatment of decompensated hepatitis C virus-induced liver cirrhosisSafety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis.Real-life practice of antiviral therapy and disease patterns of patients with chronic hepatitis B: a single-center retrospective observation study.Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease.Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting.High dose of Lamivudine and resistance in patients with chronic hepatitis B.Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis.
P2860
Q26771253-393B5507-47F9-43EB-B383-F251EA85589DQ26773224-003CA5D8-7299-4E01-A67A-0F8C73F0D6CCQ26777506-8F12A75E-759F-4CC8-B553-C3326018A2AAQ26864647-D07955A9-B25B-4152-B196-D59A2034B411Q27016136-56D4D7FB-6602-4E3A-8AA2-B82BD4688D08Q28088566-D783E565-51E5-415B-881B-B0FDF61B48B3Q30244568-C1815A67-5439-4035-AC0D-662321CA2B80Q30374334-59F9A053-170E-42A0-9D63-63A92BC1B9D0Q30374701-91D20404-0F47-47FE-9730-269FA184B111Q30459124-4A091975-92A7-477F-A48B-3EE72F455B1BQ33718267-E26676A2-110D-4F47-8BF9-3785884B6BEEQ34168459-1B152EC5-80F9-4CA4-82CF-8A06F1426BFFQ34194760-3047ED1A-9B07-478C-9354-1C7E07F71A0AQ34684406-BAC87D02-8D4F-4A8C-AEAF-43A8906D52E4Q34907270-41206496-76DF-4B4D-9F16-CD0A5BE85BEFQ35173805-754FB15E-641B-4536-BD76-6180A6400BC4Q35810550-F8C12468-F938-48E0-B23F-57A6D4100CBDQ35843093-AF443069-C513-480F-9509-7AECDC9C552FQ36101272-CB3E99F1-EA63-46AF-8B19-3B7209BEAC0EQ36502057-AFD22EE2-8B57-43E4-A44F-5AB7CC023153Q36805345-F73439DC-9CEE-4796-BB3C-34CB06FFB8FBQ36954038-A55B804F-1FD9-480C-AE3C-35ECA233EE68Q37726789-45B3024D-F776-454F-8C1D-58F86568B6BAQ38071395-BEC21C82-3B63-49BD-B708-9214747634B3Q38096069-22B0E284-0EDA-474C-AA3F-5AB9A0C837A1Q38127461-76A61EA9-F0FC-45E0-87E6-15C32CA43BD0Q38177252-084997FD-6E0A-408B-9CDB-D8FCF79D6AB6Q38252962-A9CEA636-1B32-4D85-AD03-D26AAEB65612Q38594605-D3195F17-E080-4B28-9931-993154EE3B08Q38831540-77C25209-6F33-4F5D-AA64-A05C54DEC36AQ39818738-B2DA5F88-C49A-4207-8B2A-142F29B0EB0EQ40223838-A7EC28BF-326F-4046-9942-B43F3A57A8DAQ40333567-D178C041-5E56-4597-9D19-6E1C67660487Q40579236-1B393BEF-1365-4289-B0BE-7290A3CC47E6Q40705619-A46C2B20-AED4-42D4-8581-A89D3143122CQ40934257-3FD110FE-E076-4221-9490-5C1CBD54DE14Q41062498-771518DE-C6D5-4022-BEB4-D8AF915C64C1Q41564943-A3CA6E55-5D47-4B2B-A30E-AC1C338A147CQ41762596-52997557-5F9F-4651-AA3F-3CE3B2FBE7BCQ42173543-D9103C49-F05A-41E3-9080-1D01BEDC9EBF
P2860
Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
@ast
Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
@en
Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
@nl
type
label
Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
@ast
Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
@en
Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
@nl
prefLabel
Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
@ast
Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
@en
Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
@nl
P3181
P1476
Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy
@en
P2093
Cheng-Yuan Peng
Rong-Nan Chien
P304
P3181
P356
10.1016/J.JHEP.2012.02.033
P407
P50
P577
2012-08-01T00:00:00Z